Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2026-05-09 @ 2:20 PM
Study NCT ID:
NCT00312494
Status:
COMPLETED
Last Update Posted:
2021-03-29
First Post:
2006-04-06
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
A1281143
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None